The Federal Circuit on September 16, 2024.... In the case of?Vascular Solutions LLC v. Medtronic, Inc., the U.S. Court of Appeals for the Federal Circuit recently revived a set of medical device patents related to guide extension catheters, which are used in heart procedures. The dispute centered on the interpretation of the term “substantially rigid portion” in the patents. Initially, the district court found the patents indefinite, ruling in favor of Medtronic. However, the Federal Circuit disagreed, emphasizing that patent claims can describe the same invention in different ways and do not need to be mutually exclusive. The Federal Circuit adopted a functional interpretation of the term, meaning it should be rigid enough to perform its intended function. The federal Circuit further stated: "{w}e direct the district court to conduct claim construction on a claim-by-claim basis with the understanding that, at the claim construction stage, the claims are not necessarily 'mutually exclusive' since each independent claim is a different ordered combination of limitations." The Federal Circuit vacated the district court’s judgment and remanded the case for further proceedings. Read more at: https://lnkd.in/gpQ-8Aix
Sam Tekie, P. Eng的动态
最相关的动态
-
???PTAB Denies Mito Red Light’s IPR Petition Against Joovv’s Light Therapy Patent??? This decision highlights the critical importance of presenting strong, relevant prior art in inter partes review (IPR) cases. Mito Red Light’s petition was denied due to a lack of evidence connecting the prior art to the claims—specifically, the failure to demonstrate a "plurality of lights" in a light therapy device, and reliance on non-analogous art like scent diffusers. This case underscores the need for a thorough strategy when challenging patents in the IPR process. For any IPR defense support or patent strategy needs, contact us today and follow our page for more insights on IP law and litigation! https://lnkd.in/gtKsuVYt #SethLaw #IPRDefense #PatentLitigation #PatentStrategy
MITO RED LIGHT, INC. v. JOOVV, INC., PTAB Denies Mito Red Light’s IPR Petition Against Joovv’s Light Therapy Patent. Case Summary:? Mito Red Light, Inc. filed a petition for inter partes review (IPR) challenging claims 1, 2, 3, 9, 10, 11, 16, 17, and 19 of U.S. Patent No. 11,253,719 B2, owned by Joovv, Inc. The patent relates to photobiomodulation therapy systems that use light to treat various health conditions, such as skin issues. Mito Red Light argued that the claims were obvious based on prior art, including the Dijkstra and Norwood references, which cover light therapy devices and diffuser systems. Board Decision:? The Patent Trial and Appeal Board (PTAB) denied Mito Red Light’s petition. The Board found that the petitioner failed to demonstrate a reasonable likelihood of success. A key issue was the lack of evidence showing how the cited prior art disclosed a "plurality of lights" in a light therapy device, as required by the claims. Additionally, Norwood was deemed non-analogous prior art, as it pertains to scent diffusers, not light therapy devices. Key Takeaway:? To succeed in an IPR, petitioners must present clear evidence linking the prior art to the specific claim elements. In this case, the failure to demonstrate that the prior art met the claim's "plurality of lights" requirement, combined with reliance on non-analogous prior art, led to the petition’s denial. #SethLaw #TexasLawyers #IPRDefense #PatentLitigation
-
The EPO Boards of Appeal have revoked several patents covering devices for back pain management which belong to Nevro, following oppositions from competitors Boston Scientific and Medtronic. While Nevro and Boston Scientific had previously settled all global litigation in 2022, it seems the EPO is the new centre of the companies' dispute in Europe. Read the full story now on JUVE Patent. #backpain #medicaldevices #patent
EPO new battleground in Nevro and Boston Scientific medical device dispute
juve-patent.com
-
???? Route 92 Medical files patent infringement suit against Q'Apel Medical Tenzing delivery catheters, first used clinically in 2019, are currently protected by a global portfolio of patents including 23 U.S. patents. These catheters offer a unique tapered tip designed to significantly reduce ledge effect and to provide atraumatic tracking in the neurovasculature, enabling consistent navigation to reach targeted locations in the brain without the use of a microcatheter. The Tenzing delivery catheters are available in three sizes and are designed to be delivered together with Route 92 Medical’s HiPoint?and FreeClimb?catheters as part of seamless systems, thereby enhancing the effectiveness of neurovascular procedures. Read more online: https://lnkd.in/emghV7sB ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing
-
-
As an attorney, providing comprehensive and accurate medical evidence is key to winning personal injury cases. Driving Force Company’s PI Connection, which includes Vertebral Motion Analysis (VMA?) technology, offers an advanced solution for spinal injury diagnostics. Key Benefits of VMA? for Legal Professionals: Increased Diagnostic Accuracy: Standard X-Rays often miss significant spinal injuries, with a false-negative rate of 30%. VMA? captures the spine’s full range of motion, ensuring no injury is overlooked. Detailed Motion Analysis: VMA? records video of spinal movement, splitting it into hundreds of individual images. This dynamic analysis provides a complete view of the spine, essential for detailed injury reports. Lower Radiation Exposure: VMA? produces 20% less radiation than typical X-rays, making it a safer option for your clients. Validated and Reliable: VMA? is FDA-cleared and supported by leading medical research, ensuring the highest standards of accuracy and reliability. If you need comprehensive spinal assessments for your cases, we may have a provider in your area ready to help. Contact us today to discover how VMA? can enhance your legal practice. https://shorturl.at/dZRPW #MedicalTechnology #PersonalInjuryLaw #InjuryAssessment #DrivingForceCompany
-
-
Around 270,000 people in Germany suffer a stroke each year. Until now, the standard treatment has been thrombolysis: the intravenous administration of a drug, but this may not be sufficient when large cerebral vessels are blocked. A recent international study led by the University Medical Centre Hamburg-Eppendorf and the University Medical Centre Heidelberg has shown significant benefits in using catheters when treating sufferers of a stroke. This treatment is known but until now has been considered riskier, this new long-term study shows that the success and benefits of catheter use outweighs any risk. ? Competition among catheter manufacturers is very high, which is why patent protection is particularly important. Should the German and international guidelines for the treatment of ischemic strokes be adapted in light of this study, this would likely lead to an increased demand for catheters in this new treatment. ? Join patent attorney and partner Jochen Kilchert as he reflects on this topic: https://lnkd.in/ecVp78Qh #medicalTechnology #patentprotection #newTreatment
-
-
Entrepreneur passionate about revolutionizing healthcare. Founder of Driving Force Company, empowering practices with PI Connection for better patient outcomes.
As an attorney, providing comprehensive and accurate medical evidence is key to winning personal injury cases. Driving Force Company’s PI Connection, which includes Vertebral Motion Analysis (VMA?) technology, offers an advanced solution for spinal injury diagnostics. Key Benefits of VMA? for Legal Professionals: Increased Diagnostic Accuracy: Standard X-Rays often miss significant spinal injuries, with a false-negative rate of 30%. VMA? captures the spine’s full range of motion, ensuring no injury is overlooked. Detailed Motion Analysis: VMA? records video of spinal movement, splitting it into hundreds of individual images. This dynamic analysis provides a complete view of the spine, essential for detailed injury reports. Lower Radiation Exposure: VMA? produces 20% less radiation than typical X-rays, making it a safer option for your clients. Validated and Reliable: VMA? is FDA-cleared and supported by leading medical research, ensuring the highest standards of accuracy and reliability. If you need comprehensive spinal assessments for your cases, we may have a provider in your area ready to help. Contact us today to discover how VMA? can enhance your legal practice. https://shorturl.at/dZRPW #MedicalTechnology #PersonalInjuryLaw #InjuryAssessment #DrivingForceCompany
-
-
CYROLITE is one of the only polymers which has reliability record spanning more than 40years. #CYROLITE #MedicalDevices #PolymerInnovation #HealthcareSolutions #Reliability #IndustryLeadership #MedicalTechnology #LongTermPerformance #QualityMaterials #EngineeringExcellence
You can depend on us to deliver on your CYROLITE? needs. We have never discontinued a CYROLITE? material in use by the medical device and diagnostic industry, ensuring that you always have access to our top-quality materials. ?? #roehm #cyrolite #globalleader #medicalacrylics
-
-
The Australian Competition and Consumer Commission (ACCC ) has announced its decision not to oppose Cochlear's proposed acquisition of the cochlear implants business of Oticon Medical from its parent company, Demant. #ACCC #Cochlear #OticonMedical #Demant #BusinessAcquisition #CompetitionRegulation #HearingTechnology #MarketConsolidation #RegulatoryApproval #BusinessDeal
The ACCC will not oppose Cochlear proposed acquisition of Oticon Medical
https://www.youtube.com/
-
Surgical complications: avoiding the pain of the surgical method exclusion in Europe ? Did you know that even without explicit surgical steps, a patent application can still be rejected by the European Patent Office if a surgical step is considered implicit? ? Join Julia Venner and Nick Noble for the first webinar in our MedTech autumn series where they will dive into: ? ? What constitutes a surgical step in method claims; ? How unclaimed surgical steps can be read into a claim; and ? Tips on drafting applications to avoid surgical method objections. ? Event details: Date: Tuesday 24 September 2024 Time: 9:00am PDT | 12:00pm EDT | 5:00pm BST | 6:00pm CEST Duration: 30 minutes ? Don't miss out on this insightful session! Register now to learn how to navigate the complexities of European patent objections in the MedTech field. ? Register here: https://lnkd.in/e5k3Cq4t ? #MedTech #Patents #Webinar #EuropeanPatents #SurgicalMethods
24 September 2024 - Surgical complications: avoiding the pain of the surgical method exclusion in Europe
kilburnstrode.com
-
New guidance from the EU Commission on vigilance reporting is now available. The MDCG has published 4 new guidance documents that provide examples for certain device groups on what needs individual reporting, what can go in a periodic summary report, and what could go in a trend report. The guidance is focused on Cardiac Ablation, Coronary Stents, Cardiac Implantable Electronic Devices, and Breast Implants. To access the documents, click the link here: https://lnkd.in/gXZRdAGU
Guidance - MDCG endorsed documents and other guidance
health.ec.europa.eu
Very informative